Table: Wakamoto Pharm -2024/25 parent results

Wakamoto Pharmaceutical Co

15/05/2025 08:02

May 15 (Reuters)- 
          Wakamoto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           7.79            7.74           10.00                 
               (+0.7 pct)      (-10.6 pct)    (+28.4 pct)              
  Operating   loss 457 mln    loss 195 mln      200 mln                
  Recurring   loss 409 mln    loss 161 mln      250 mln                
  Net            64 mln          108 mln        200 mln                
               (-40.9 pct)     (-21.2 pct)   (+210.4 pct)              
  EPS           1.85 yen        3.13 yen       5.76 yen                
  Ann Div       3.00 yen        3.00 yen       3.00 yen                
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       3.00 yen        3.00 yen       3.00 yen                
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T